chikungunya vlp
Vaccineexperimental
Clinical trial activity
1 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Oct 15, 2019 (NCT03992872)
Timeline
2010s
- Jan 1, 2019
Earliest Phase 2 Sponsor(trial)
Indications
Studied for
Mechanism of action
- Chikungunya virusImmunity, active
immunity, active - chikungunya virus
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT03992872 | Phase 2 | Oct 15, 2019 | PaxVax, Inc., United States Army |
Showing 1 of 1 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| PaxVax, Inc. | For profit | 1 | 1 | 1 | 2019 |
| United States Army | Government | 1 | 0 | 1 | 2019 |
2 organizations
Page 1 / 1